Visualizar Tese - Instituto de Biociências - Unesp

[37] Luo X, Ding L, Xu J et al. (2005) Gene expression profiling of leiomyoma andmyometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinol146: 1097–1118.[38] Dimitrova IK, Richer JK, Rudolph MC et al. (2009) Gene expression profiling ofmultiple leiomyomata uteri and matched normal tissue from a single patient. Fertil Steril 91:2650-2663.[39] Crabtree JS, Jelinsky SA, Harris HA et al. (2009) Comparison of human and rat uterineleiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.Cancer Res 69: 6171-6178.[40] Shah AA, Grainger DA (1996) Contemporary Concepts in Managing Menorrhagia.Medscape Womens Health 12: 8.[41] Behera MA, Feng L, Yonish B et al. (2007) Thrombospondin-1 and Thrombospondin-2mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to thegenes COL1A1 and COL3A1 and to the collagen cross-link ydroxyproline. Reprod Sci 14:63-76.[42] Desai SS, Hentz VR (2011) The treatment of dupuytren disease. J Hand Surg Am 36:936-942.[43] Shih B, Bayat A (2010) Scientific understanding and clinical management of Dupuytrendisease. Nat Rev Rheumatol 6: 715-726.[44] Yu L, Saile K, Swartz CD et al. (2008) Differential expression of receptor tyrosinekinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas. Mol Med14:264-275.[45] Anania CA, Stewart EA, Quade BJ et al. (1997) Expression of the fibroblast growthfactor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod3: 685-691.[46] Shiang CY, Qi Y, Wang B et al. (2010) Amplification of fibroblast growth factorreceptor-1 in breast cancer and the effects of brivanib alaninate. Breast Cancer Res Treat 123:747-755.[47] Keisner SV, Shah SR (2011) Pazopanib: the newest tyrosine kinase inhibitor for thetreatment of advanced or metastatic renal cell carcinoma. Drugs 71:443-454.[48] Villard E, Perret C, Gary F et al. (2011) A genome-wide association study identifies twoloci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 32:1065-1076.[49] Hou XJ, Zhang YZ, Liu X et al. (2009) Expressions of IGFBP-5, cFLIP in cervicalintraepithelial neoplasia, cervical carcinoma and their clinical significances: a molecularpathology. J Exp Clin Cancer Res 28: 1-16.[50] Taylor KJ, Sims AH, Liang L et al. (2010) Dynamic changes in gene expression in vivopredict prognosis of tamoxifen-treated patients with breast cancer. Breast Cancer Res 12:R39.[51] Galiègue-Zouitina S, Delestré L, Dupont C et al. (2008) Underexpression of RhoH inHairy Cell Leukemia. Cancer Res, 68:4531-4540.[52] Chegini N, Kornberg L (2003) Gonadotropin releasing hormone analogue therapy alterssignal transduction pathways involving mitogen-activated protein and focal adhesion kinasesin leiomyoma. J Soc Gynecol Investig 10:21-26.18